retatrutide triple agonist gip glp-1 glucagon Retatrutide—A Game Changer in Obesity Pharmacotherapy retatrutide mechanism triple agonist gip
Description
Brazg R., Xu L., Dalla Man C., Cobelli C., Thomas K., and Stein P
R.et al (2017)
GLP-1 is produced in the cells lining the intestines, which makes gut health important
Drug interactions and metabolism Weight loss associated with GLP-1R use may alter drug metabolism of weight-based medications (e.g., levothyroxine, warfarin )
Pregnant women exposed to semaglutide and healthcare providers are encouraged to contact Novo Nordisk at 1-800-727-6500
